564 related articles for article (PubMed ID: 11035810)
21. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
22. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes.
Tang Q; Gonzales M; Inoue H; Bowden GT
Cancer Res; 2001 Jun; 61(11):4329-32. PubMed ID: 11389054
[TBL] [Abstract][Full Text] [Related]
23. Activity of glycogen synthase kinase-3beta is down-regulated during transient differentiation of human colon cancer HT-29 cells.
Tuhackova Z; Sloncova E; Hlavacek J; Sovova V; Velek J
Oncol Rep; 1999; 6(4):827-32. PubMed ID: 10373664
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells.
Hajduch E; Alessi DR; Hemmings BA; Hundal HS
Diabetes; 1998 Jul; 47(7):1006-13. PubMed ID: 9648821
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal.
Crowder RJ; Freeman RS
J Biol Chem; 2000 Nov; 275(44):34266-71. PubMed ID: 10954722
[TBL] [Abstract][Full Text] [Related]
26. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
27. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
Ebert AD; Wechselberger C; Frank S; Wallace-Jones B; Seno M; Martinez-Lacaci I; Bianco C; De Santis M; Weitzel HK; Salomon DS
Cancer Res; 1999 Sep; 59(18):4502-5. PubMed ID: 10493495
[TBL] [Abstract][Full Text] [Related]
28. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
Cross DA; Alessi DR; Cohen P; Andjelkovich M; Hemmings BA
Nature; 1995 Dec 21-28; 378(6559):785-9. PubMed ID: 8524413
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation.
Rogatsky I; Waase CL; Garabedian MJ
J Biol Chem; 1998 Jun; 273(23):14315-21. PubMed ID: 9603939
[TBL] [Abstract][Full Text] [Related]
31. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
Yuan H; Mao J; Li L; Wu D
J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
[TBL] [Abstract][Full Text] [Related]
32. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis.
Ueki K; Yamamoto-Honda R; Kaburagi Y; Yamauchi T; Tobe K; Burgering BM; Coffer PJ; Komuro I; Akanuma Y; Yazaki Y; Kadowaki T
J Biol Chem; 1998 Feb; 273(9):5315-22. PubMed ID: 9478990
[TBL] [Abstract][Full Text] [Related]
33. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
Jensen J; Brennesvik EO; Lai YC; Shepherd PR
Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
[TBL] [Abstract][Full Text] [Related]
34. GSK-3beta negatively regulates skeletal myotube hypertrophy.
Vyas DR; Spangenburg EE; Abraha TW; Childs TE; Booth FW
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C545-51. PubMed ID: 12107064
[TBL] [Abstract][Full Text] [Related]
35. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
[TBL] [Abstract][Full Text] [Related]
36. Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor.
Ballou LM; Tian PY; Lin HY; Jiang YP; Lin RZ
J Biol Chem; 2001 Nov; 276(44):40910-6. PubMed ID: 11533051
[TBL] [Abstract][Full Text] [Related]
37. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).
Dickson LM; Lingohr MK; McCuaig J; Hugl SR; Snow L; Kahn BB; Myers MG; Rhodes CJ
J Biol Chem; 2001 Jun; 276(24):21110-20. PubMed ID: 11274216
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Lochhead PA; Coghlan M; Rice SQ; Sutherland C
Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
[TBL] [Abstract][Full Text] [Related]
39. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA
Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654
[TBL] [Abstract][Full Text] [Related]
40. Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle.
Lin Y; Brady MJ; Wolanske K; Holbert R; Ruderman NB; Yaney GC
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E318-25. PubMed ID: 12110537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
